Badger to Provide Technology for Styrene Monomer Plant in China
Badger Licensing LLC (Badger) said that Zhejiang Petroleum & Chemical Co Ltd (ZPC) has selected Badger’s proprietary technology for a 1200 KTA grassroots ethylbenzene/styrene monomer (EB/SM) plant being built in Daxiaoyushan Island, China. The contract includes technology license, process design and start-up services.
The new plant, one of the largest EB/SM plants in the world, will utilize Badger’s proprietary EBMax1 technology integrated with Badger’s proprietary styrene technology. Basic engineering design work has begun and the plant is scheduled for mechanical completion and startup in 2018.
Styrene monomer, with a worldwide capacity of over 30 million metric tons per annum, is a precursor to the production of a variety of polymer derivatives, including polystyrene (PS), acrylonitrile butadiene styrene (ABS), and styrene butadiene rubber (SBR). Badger’s EBMax and styrene technologies have been licensed more than 30 and 50 times, respectively, for plants around the world.
Badger Licensing LLC, headquartered in Boston, Massachusetts, is a venture of affiliates of TechnipFMC and ExxonMobil.
“Badger’s unique capabilities and experience in scale-up and designing EB/SM plants of this size, in conjunction with the advantages that our innovative technologies offer, were instrumental in this award. We are proud that ZPC has selected Badger’s technologies and we look forward to working with them on this significant project to ensure the successful design, startup and operation of the plant,” said Dana Johnson, president of Badger.
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Wanhua Chemical Announces 2026 Investment Plan: RMB 27.3 Billion for Projects Plus RMB 2.22 Billion for Equity Investments
-
BASF Raises API and Excipient Prices
-
Nylon Giant to Close Another European Plant, Cutting 140 Jobs
-
argenx to Acquire Forte Biosciences for $2.2 Billion in Major Autoimmune Antibody Deal
-
Croda’s First-Half Profit Outpaces Sales as Beauty Actives Grow 19%
-
GACL Approves Additional Hydrochloric Acid Unit at Dahej
-
Dover to Acquire Cloeren and Expand Its Polymer-Extrusion Equipment Portfolio
-
Huntsman Issues Two Consecutive MDI Price Hike Notices: €250 Increase in Europe, $300 Increase in India
-
Nouryon's Production Facilities in China Have Obtained Halal Certification for Personal Care Ingredients
-
Two Major Dye Giants Hike Prices Consecutively: Longsheng Raises Prices by Up to RMB 10,000/Ton, Yabang Increases Some Products by RMB 60,000/Ton
Recommend Reading
-
Aster Opens Singapore’s Storage and Marine Network to Third Parties
-
Iran Fully Halts Petrochemical Exports as the Middle East Supply System Faces Restructuring
-
Dow Q3 2025: Struggling at the Bottom of the Cycle Amid a Slow Structural Recovery
-
Evonik Supervisory Board Approves Executive Changes, Extends Kullmann’s Term to 2030
-
5%–10% Is Just the Surface: Behind Dow’s Greater China Price Letter Lies a Global Repricing of Silicones
-
April Isopropyl Alcohol Market Price Rises First, Then Falls
-
Business Society’s Market Outlook for Propylene Oxide on August 28, 2026: Price Trend Is Expected to Be Volatile
-
Business Society’s Market Outlook for Caustic Soda on August 31, 2026: Consolidation and Volatility
-
Business Society’s Market Outlook for Phthalic Anhydride on August 28, 2026: Deep Correction Favors a Bearish View
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies